Сравнение

Ganirelix vs. Histrelin

Два пептида рядом — идентичность, доказательная база, правовой статус и известные нежелательные явления.

Идентичность

Категория

Исследования (прочее)

Номер CAS

123246-29-7

220810-26-4

Молекулярная масса

1570.3 g/mol

1323.52 g/mol

Период полувыведения

нет данных

Последовательность

нет данных

Механизм действия

Ganirelix

Ganirelix competitively and reversibly binds the pituitary GnRH receptor, rapidly suppressing LH (and, less so, FSH) release — without the initial hormone 'flare' of GnRH agonists.

Histrelin

Continuous GnRH-agonist stimulation downregulates and desensitises the pituitary GnRH receptors — after the initial rise, LH, FSH and the sex hormones fall persistently.

Доказательная база

Наивысшая доказательность

РКИ на людях

Исследования

из них на людях

Зафиксированные эффекты

Открытые противоречия

Задокументированные нежелательные явления

Правовой статус

Country	Ganirelix	Histrelin
Германия	Рецептурный	Рецептурный
США	Рецептурный	Рецептурный

Полные записи

Frequently asked questions

What is the difference between Ganirelix and Histrelin?: Ganirelix is classified as "Исследования (прочее)", while Histrelin is classified as "Исследования (прочее)". Ganirelix: Ganirelix is a synthetic decapeptide and GnRH antagonist. In assisted reproduction (IVF) it prevents the premature LH surge during controlled ovarian stimulation. Histrelin: Histrelin is a nonapeptide GnRH agonist delivered as a once-yearly implant. Approved for central precocious puberty in children (Supprelin LA) and advanced prostate cancer (Vantas). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Ganirelix or Histrelin?: The highest available evidence level is "РКИ на людях" for Ganirelix and "РКИ на людях" for Histrelin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Ganirelix and Histrelin in Germany and the United States?: Германия: Ganirelix — Рецептурный, Histrelin — Рецептурный. США: Ganirelix — Рецептурный, Histrelin — Рецептурный. These are factual summaries with source and review date on the individual pages.

Country

Ganirelix

Histrelin

Германия

Рецептурный

США

Рецептурный

Frequently asked questions

What is the difference between Ganirelix and Histrelin?

Ganirelix is classified as "Исследования (прочее)", while Histrelin is classified as "Исследования (прочее)". Ganirelix: Ganirelix is a synthetic decapeptide and GnRH antagonist. In assisted reproduction (IVF) it prevents the premature LH surge during controlled ovarian stimulation. Histrelin: Histrelin is a nonapeptide GnRH agonist delivered as a once-yearly implant. Approved for central precocious puberty in children (Supprelin LA) and advanced prostate cancer (Vantas). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Ganirelix or Histrelin?

The highest available evidence level is "РКИ на людях" for Ganirelix and "РКИ на людях" for Histrelin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Ganirelix and Histrelin in Germany and the United States?

Германия: Ganirelix — Рецептурный, Histrelin — Рецептурный. США: Ganirelix — Рецептурный, Histrelin — Рецептурный. These are factual summaries with source and review date on the individual pages.